Trine Alma Knudsen

15PUBLICATIONS
83CO-AUTHORS
Haematological tumoursPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

|Sep 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.

Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler

|Jun 04, 2025
Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.

Lasse M Obel, Joachim S Skovbo, Axel C P Diederichsen

|Aug 20, 2024
Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera.

Anders Lindholm Sørensen, Vibe Skov, Lasse Kjær

|Jan 16, 2024
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.

Christina Schjellerup Eickhardt-Dalbøge, Henrik V Nielsen, Kurt Fuursted

|Sep 11, 2023
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia.

Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik V Nielsen

Pageof 3

Frequent Collaborators

15 joint publications

Vibe Skov

13 joint publications

Hans Hasselbalch

7 joint publications

Christina Ellervik

6 joint publications

Morten Kranker Larsen